Gyre Therapeutics (GYRE) Stock Price & Financial Analysis
Gyre Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Gyre Therapeutics
What is the current stock price for GYRE?
As of the latest trading session, GYRE stock trades at $7.12. The 52-week range is $6.11–$11.78, with a day range of $6.91–$7.18.
What is the P/E ratio for GYRE?
Gyre Therapeutics's trailing P/E ratio is 113.0, meaning investors pay $113.0 for every $1 of annual earnings. Gyre Therapeutics operates in the Healthcare sector.
Does GYRE pay dividends?
Gyre Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GYRE?
Analyst ratings and recommendations for GYRE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of GYRE?
Gyre Therapeutics's market capitalization is $740.3M, classifying it as a small-cap company. Gyre Therapeutics operates in the Healthcare sector within the Biotechnology industry.